Quick Heal Technologies Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter
- September 17, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Heal Technologies share price Rs 155.51 on 17 September 2026, down 1.16%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 5.28 crore loss. Q2 FY26 base a profit of Rs 7.91 crore.
Quick Answer
The Quick Heal Technologies Q2 results date for FY27 is not confirmed, and Quick Heal Technologies Ltd. had not filed a board meeting intimation with the NSE or BSE as of 17 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 83.52 crore in revenue and a profit of Rs 7.91 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.
The Quick Heal Technologies Q2 results FY27 announcement is the next scheduled earnings event for Quick Heal Technologies Ltd., Quick Heal Technologies develops cybersecurity and antivirus software for consumers and enterprises in India under its Quick Heal and Seqrite brands.. The stock traded at Rs 155.51 on the NSE on 17 September 2026, down 1.16% from the previous close of Rs 157.33, about 58.1% below its 52-week high of Rs 371.40 and 24.4% above its 52-week low of Rs 125.00.
What makes the Quick Heal Technologies Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 83.52 crore of revenue and a profit of Rs 7.91 crore, while the most recent quarter on record, Q1 FY27, produced Rs 44.99 crore and a loss of Rs 5.28 crore. Everything below is built from those reported figures rather than from any forecast.
Click Here – Get Free Investment Predictions
When Is the Quick Heal Technologies Q2 Results FY27 Date?
The Quick Heal Technologies Q2 results date for FY27 is not confirmed. As of 17 September 2026, Quick Heal Technologies Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.
Also read – Jindal Saw Q2 Results FY27 Preview: Results Date, Expectations
What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Quick Heal Technologies Q2 results date becomes public through that filing rather than through any advance announcement.
The Quick Heal Technologies Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Quick Heal Technologies.
Quick Heal Technologies Q2 Results Expectations: What the Market Is Actually Tracking
No verified analyst estimate for the Quick Heal Technologies Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Quick Heal Technologies. The Quick Heal Technologies Q2 results watchlist below is built from what the company has actually reported and disclosed.
Quick Heal Technologies Q2 results for the September 2026 quarter come after a stretch of genuinely volatile performance rather than any steady trend in either direction. The company has swung between net losses and net profits across its last five reported quarters, with no clear pattern of sustained improvement or deterioration. That volatility is the key backdrop against which Quick Heal Technologies Q2 results for the September 2026 quarter should be viewed.
Revenue has also moved around considerably in the period leading up to Quick Heal Technologies Q2 results, rising to a high point before declining sharply in the two most recent quarters. Operating margin has been especially erratic, turning sharply negative in the weakest quarter before recovering somewhat, which points to inconsistent cost control alongside the revenue swings. Profitable quarters have essentially been sandwiched between loss-making ones, making it difficult to identify a durable direction in the underlying business.
Also read – JK Lakshmi Cement Q2 Results FY27 Preview: Results Date, Expectations
As a result, Quick Heal Technologies Q2 results for the September 2026 quarter carry more uncertainty than usual, since the recent history offers no clear improving or worsening trend to extrapolate from. Both return on equity and return on capital employed remain negative on a trailing basis, reflecting the net effect of this uneven run of quarters. The honest read heading into the September 2026 quarter is that this remains a volatile business currently weak on trailing profitability measures, not one in a settled recovery.
Check Quick Heal Technologies Ltd. Live Fundamentals on the Univest Screener
Quick Heal Technologies Q2 Results Preview: The Q1 FY27 Actuals It Builds On
Quick Heal Technologies Ltd. reported revenue of Rs 44.99 crore in Q1 FY27, down 21.39% from Rs 57.23 crore in Q1 FY26, and a loss of Rs 5.28 crore at the net level, a narrower loss than the Rs 5.51 crore loss of Q1 FY26. These are reported actuals, not estimates.
Sequentially, revenue was down 7.67% over the March 2026 quarter figure of Rs 48.73 crore, and net profit was a narrower loss than the Rs 19.94 crore loss of Q4 FY26. Operating margin stood at negative 17.0% in Q1 FY27 against 11.05% in the September 2025 quarter, which is the comparison the Quick Heal Technologies Q2 results print will be read against.
Q2 FY26 Base: The Comparison Quick Heal Technologies Q2 Results FY27 Must Beat
Quick Heal Technologies Ltd. reported revenue of Rs 83.52 crore and a profit of Rs 7.91 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Quick Heal Technologies Q2 results preview.
Because the base quarter itself was loss-making, a year-on-year percentage comparison of profit is not meaningful for Quick Heal Technologies. The more useful test in the Quick Heal Technologies Q2 results print is whether the company reports a profit at all, and how the income line of Rs 83.52 crore compares with the Rs 44.99 crore of the June 2026 quarter.
Quick Heal Technologies Quarterly Results Trend Over the Last Four Quarters
| Quarter | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q2 FY26 (Sep 2025) | 83.52 | 7.91 |
| Q3 FY26 (Dec 2025) | 71.54 | 6.61 |
| Q4 FY26 (Mar 2026) | 48.73 | (19.94) |
| Q1 FY27 (Jun 2026) | 44.99 | (5.28) |
Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company’s exchange filings, and they are the only basis this Quick Heal Technologies Q2 results preview uses.
Revenue across those four quarters ranged from Rs 44.99 crore to Rs 83.52 crore, and net profit from Rs 19.94 crore loss to Rs 7.91 crore. That spread is the honest context for the Quick Heal Technologies Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.
Key Factors That Could Shape Quick Heal Technologies Q2 Results FY27
The Quick Heal Technologies Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Quick Heal Technologies has already reported.
A Volatile, Non-Linear Earnings Pattern
The most important factor around Quick Heal Technologies Q2 results is that profitability has swung back and forth rather than trended in one direction. Net losses in two of the last five quarters have alternated with profitable quarters in between, and the most recent quarter itself was also a loss. This pattern makes Quick Heal Technologies Q2 results harder to forecast from recent history than for a company with a steadier trend.
Sharp Swings in Revenue and Operating Margin
Revenue climbed to its highest point in the window before falling in the two subsequent quarters, and operating margin followed an even more extreme path, turning deeply negative in the weakest quarter before improving somewhat. This kind of swing suggests that both demand and cost structure have been unsettled rather than steadily improving. It is a factor that will weigh on how Quick Heal Technologies Q2 results are interpreted regardless of the headline number.
Weak Trailing Return Ratios
With return on equity and return on capital employed both in negative territory on a trailing basis, the company’s recent profitability record has not been strong enough to generate positive returns on capital employed over the last year. This trailing weakness is a direct consequence of the net losses recorded in three of the last five quarters. It forms an important part of the context for reading Quick Heal Technologies Q2 results honestly, without assuming a turnaround has taken hold.
Quick Heal Technologies Q2 Results FY27: Share Price and Valuation Going Into the Print
Quick Heal Technologies share price today is Rs 155.51 on the NSE, down Rs 1.82 or 1.16% from the previous close of Rs 157.33 on 17 September 2026, ahead of the Quick Heal Technologies Q2 results announcement.
| Metric | Value (17 September 2026) |
|---|---|
| NSE Symbol | QUICKHEAL |
| Current Market Price | Rs 155.51 |
| 52-Week High | Rs 371.40 |
| 52-Week Low | Rs 125.00 |
| Market Capitalisation | Rs 846 crore |
| PE Ratio | Not meaningful on a trailing loss |
| PB Ratio | 1.93 |
| EPS (TTM) | Not meaningful on a trailing loss |
| Book Value per Share | Rs 80.50 |
| Debt to Equity | 0.00 |
| Return on Equity | -3.82% |
| 50-Day Moving Average | Rs 151.80 |
| 200-Day Moving Average | Rs 185.72 |
| RSI (14) | 71.90 |
The stock trades above its 50-day average of Rs 151.80 but below its 200-day average of Rs 185.72, with a 14-day RSI of 71.90. None of this is a view on where the shares go once the Quick Heal Technologies Q2 results are announced, and no price target is offered here.
Download the Univest iOS App or Univest Android App to track Quick Heal Technologies Ltd. live price and quarterly earnings updates.
What Investors Should Watch When Quick Heal Technologies Q2 Results Are Announced
Four lines carry most of the information in a company of this size, and reading them in order keeps the Quick Heal Technologies Q2 results print in proportion.
- Revenue against the Rs 83.52 crore reported in the September 2025 base quarter
- Net profit against a profit of Rs 7.91 crore in that same quarter
- Operating margin against negative 17.0% in Q1 FY27
- Any exceptional item, provision or one-off gain disclosed alongside the numbers
A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Quick Heal Technologies Q2 results announcement should be read together with the notes to the results rather than the headline alone.
Conclusion on Quick Heal Technologies Q2 Results FY27
The Quick Heal Technologies Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Quick Heal Technologies Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.
On that basis the Quick Heal Technologies Q2 results FY27 print faces a base of Rs 83.52 crore in revenue and a profit of Rs 7.91 crore, with the most recent quarter having delivered Rs 44.99 crore and a loss of Rs 5.28 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Quick Heal Technologies, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Quick Heal Technologies Q2 Results FY27
What is the Quick Heal Technologies Q2 results date for FY27?
Ans. The Quick Heal Technologies Q2 results date for FY27 is not confirmed. Quick Heal Technologies Ltd. had not filed a board meeting intimation with the NSE or BSE as of 17 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.
What quarter do the Quick Heal Technologies Q2 results 2026 cover?
Ans. The Quick Heal Technologies Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Quick Heal Technologies Ltd. reports revenue, operating profit and net profit for that period, and the Quick Heal Technologies Q2 results filing also carries the notes to the accounts.
What were the Quick Heal Technologies Q1 FY27 results?
Ans. Quick Heal Technologies Ltd. reported revenue of Rs 44.99 crore in Q1 FY27 and a loss of Rs 5.28 crore at the net level. Revenue was down 21.39% versus Q1 FY26 and net profit was a narrower loss than the Rs 5.51 crore loss of Q1 FY26.
What were Quick Heal Technologies Q2 FY26 results in the September 2025 quarter?
Ans. Quick Heal Technologies Ltd. reported revenue of Rs 83.52 crore and a profit of Rs 7.91 crore in Q2 FY26. Operating margin was 11.05%. Those figures form the base for the Quick Heal Technologies Q2 results FY27 comparison.
What are the main Quick Heal Technologies Q2 results expectations this quarter?
Ans. No verified analyst estimate is publicly available. The Quick Heal Technologies Q2 results expectations centre on revenue against the Rs 83.52 crore base, net profit against a profit of Rs 7.91 crore, operating margin against negative 17.0% in Q1 FY27, and any exceptional item disclosed with the numbers.
What is Quick Heal Technologies share price today ahead of the Q2 earnings?
Ans. Quick Heal Technologies share price is Rs 155.51 on the NSE as of 17 September 2026, down 1.16% from Rs 157.33. The stock is about 58.1% below its 52-week high of Rs 371.40 and 24.4% above its 52-week low of Rs 125.00, at a market capitalisation of Rs 846 crore.
Is Quick Heal Technologies a good stock to buy before the Q2 results?
Ans. This article does not offer a buy, sell or hold recommendation on Quick Heal Technologies Ltd. The stock trades at a price-to-book ratio of 1.93 with a return on equity of -3.82%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.
